v3.25.3
Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Income Statement [Abstract]        
Federal grants $ 493,104 $ 3,418,853 $ 3,184,314 $ 3,906,372
Operating expenses:        
Research and development 2,954,909 1,690,674 6,763,866 3,416,807
General and administrative 1,279,290 1,083,433 3,879,569 3,643,223
Total operating expenses 4,234,199 2,774,107 10,643,435 7,060,030
Income (loss) from operations (3,741,095) 644,746 (7,459,121) (3,153,658)
Other income (expense):        
Change in fair value of liability classified warrants 998 6,403 10,061 23,175
Interest expense, net (6,369) (4,063) (13,385) (1,279,691)
Other income and expense, net 17,338 14,683 54,227 (12,413)
Total other income (expense), net 11,967 17,023 50,903 (1,268,929)
Net income (loss) (3,729,128) 661,769 (7,408,218) (4,422,587)
Net loss attributable to noncontrolling interests (166) (74)
Deemed dividend related to warrants down round provision 290
Net income (loss) attributable to common stockholders $ (3,729,128) $ 661,769 $ (7,408,052) $ (4,422,803)
Net income (loss) per basic and diluted share:        
Net income (loss) per share attributable to common stockholders, basic $ (1.29) $ 1.00 $ (3.42) $ (8.52)
Net income (loss) per share attributable to common stockholders, diluted $ (1.29) $ 1.00 $ (3.42) $ (8.52)
Weighted average common shares outstanding, basic 2,886,059 659,361 2,168,247 518,838
Weighted average common shares outstanding, diluted 2,886,059 659,361 2,168,247 518,838

Source

PDF HTML
ZIP XBRL